Viemed HealthcareVMD +0.54%93 5-Year ROIIC % is -11.15 as of Dec. 2025. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.90 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 733 Medical Devices & Instruments companies, Viemed Healthcare ranks worse than 66.17% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Viemed Healthcare's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was -11.15%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Viemed Healthcare's 5-Year ROIIC % or its related term are showing as below:
VMD's 5-Year ROIIC % is ranked worse than 66.17% of 733
companies
in the Medical Devices & Instruments industry
Industry Median: 1.04
vs VMD: -11.15
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Viemed Healthcare 5-Year ROIIC % Related Terms
Viemed Healthcare 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare 5-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's 5-Year ROIIC % falls into.
Viemed Healthcare's 5-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( 14.629544 (Dec. 2025) - 24.453 (Dec. 2020) )
/
( 166.77 (Dec. 2025) - 78.7 (Dec. 2020) )
=
-9.823456
/
88.07
=
-11.15%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Viemed Healthcare (VMD) has a 5-Year ROIIC % of -11.15 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Viemed Healthcare and its competitors. According to the industry distribution chart, Viemed Healthcare ranks #485 out of 733 companies in the Medical Devices & Instruments industry, placing it in the top 66.2%.
Is Viemed Healthcare's 5-Year ROIIC % too high?
Viemed Healthcare's current 5-Year ROIIC % is -11.15. Based on the distribution chart, Viemed Healthcare ranks #485 out of 733 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's 5-Year ROIIC % compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #485 out of 733 companies for 5-Year ROIIC %. This places Viemed Healthcare in the lower half of its industry. The industry median 5-Year ROIIC % is 1.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Devices & Instruments company?
The median 5-Year ROIIC % among Medical Devices & Instruments companies is 1.04, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median 5-Year ROIIC % is 1.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current 5-Year ROIIC % is -11.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.90, compared to a current price of $12.14 — trading 11.4% above its estimated fair value. The current 5-Year ROIIC % is -11.15. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current 5-Year ROIIC % is -11.15 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of $12.14 is trading 11.4% above its estimated GF Value™ of $10.90.
GuruFocus considers Viemed Healthcare to be Modestly Overvalued.
Key valuation signals for VMD:
5-Year ROIIC %: -11.15
GF Value™: $10.90 vs. price of $12.14 (11.4% above fair value)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score
Get the complete analysis for VMD
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
